AI Agent Performs Brain Surgery on Live Mouse
An AI agent successfully injected gene therapy into a live mouse's brain to treat epilepsy.
"Whoa, an AI just did brain surgery on a mouse! This is wild – AI is getting hands-on in the lab, literally. Future research just got a major upgrade."
A biotech startup, Exin Therapeutics, utilized an AI agent to perform a controversial brain surgery on a live mouse. The agent successfully selected and injected a gene therapy treatment into the mouse's brain using a motorized surgery rig. This experiment offers a glimpse into the future of research labs, where AI agents could become active participants in scientific procedures.
Initially, Anthropic's Claude Opus 5.5 model was tested but refused to guide the needle into the mouse's brain, citing potential danger to the animal. The team then switched to Claude Sonnet 5, which proceeded with the procedure. The AI agent chose from 19 gene therapy options, selected the brain region and injection coordinates, and controlled the robotic arms, injector needle, and parameters like volume and speed.
This event highlights the potential for AI models to be integrated with real-world experiments, making them more reliable by providing direct access to lab equipment. While safeguards were in place, including human approval for injection plans and an emergency button, the experiment demonstrates a significant step towards AI agents directly interacting with physical scientific processes.
This development indicates a shift towards AI models directly executing complex physical tasks in research, potentially accelerating drug discovery and scientific breakthroughs. Businesses in biotech and AI development should note the increasing autonomy of AI agents in laboratory settings, which could redefine research methodologies and operational efficiencies.
Related stories
Relevant tools
Find the right AI tool for your business
Chat with Insta and get matched to the right tool in seconds.
Try Insta Tool Finder →